Bimekizumab Safety in Patients With Moderate to Severe Psoriasis: Analysis of Pooled Data from Phase 2 and 3 Clinical Trials. J of Skin 2021, 5 (1), s21. https://doi.org/10.25251/skin.5.supp.21.